More articles from REPLY

You have access
Reply: Unraveling the Hypocalcemic Response to ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Therapy
Shejil Kumar, Megan Crumbaker and Louise Emmett

Journal of Nuclear Medicine February 1, 2024, 65 (2) 333-334; DOI: https://doi.org/10.2967/jnumed.123.266768
You have access
Reply: Recent Evidence on Cardiac ^99mTc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis
Christoph Rischpler, David Kersting, Lukas Kessler, Zohreh Varasteh, Peter Luedike, Alexander Carpinteiro, Tienush Rassaf, Ken Herrmann and Maria Papathanasiou

Journal of Nuclear Medicine February 1, 2024, 65 (2) 330; DOI: https://doi.org/10.2967/jnumed.123.266767
You have access
Reply to “Theranostics Is Not Radiotheranostics”
Wolfgang Andreas Weber

Journal of Nuclear Medicine December 1, 2023, 64 (12) 2002; DOI: https://doi.org/10.2967/jnumed.123.266491

Main menu